Ventrus Biosciences Inc  

(Public, NASDAQ:VTUS)   Watch this stock  
Find more results for VTUS
0.00 (0.00%)
Apr 15 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 1.01 - 4.69
Open     -
Vol / Avg. 0.00/562,343.00
Mkt cap 24.57M
P/E     -
Div/yield     -
EPS -1.00
Shares 23.40M
Beta 0.03
Inst. own 42%

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -59.30% -86.08%
Return on average equity -64.05% -94.72%
Employees 8 -
CDP Score - -


5th Floor, 99 Hudson Street
NEW YORK, NY 10013
United States - Map
+1-646-7065208 (Phone)
+1-646-7065101 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Ventrus Biosciences, Inc. (Ventrus) is a specialty pharmaceutical company focused on the development and commercialization of late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoids, anal fissures and fecal incontinence. Its product candidate portfolio consists of three late-stage drugs intended to treat these conditions: one new chemical entity (NCE) and two previously approved molecules that will have market exclusivity for new and patentable topical gastrointestinal indications. The Company�s three late-stage product candidates are Iferanserin ointment (VEN 309) for the treatment of hemorrhoids, Diltiazem cream (VEN 307), a treatment for the relief of pain associated with anal fissures and Phenylephrine gel (VEN 308) for the treatment of fecal incontinence associated with ileal pouch anal anastomosis (IPAA). On November 14, 2011, the Company acquired Sam Amer & Co.

Officers and directors

Russell H. Ellison M.D. Chairman of the Board, Chief Executive Officer, Chief Medical Officer
Age: 65
Bio & Compensation  - Reuters
David J. Barrett Chief Financial Officer
Age: 60
Bio & Compensation  - Reuters
Anthony E. Altig Independent Director
Age: 57
Bio & Compensation  - Reuters
Mark Auerbach CPA Independent Director
Age: 75
Bio & Compensation  - Reuters
Joseph Felder M.D. Independent Director
Age: 52
Bio & Compensation  - Reuters
Myron Z. Holubiak Independent Director
Age: 66
Bio & Compensation  - Reuters